SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 ...

That’s the potential promise of a new study on a drug made by Japanese pharmaceutical company Shionogi. At a scientific ...

Results saw all 24 healthy volunteers who made it to the 72-week mark still had effective levels of dMAB in their systems.

The virus that causes COVID-19 continues to mutate. Scientists say that's likely to continue indefinitely, and the virus will ...

A study led by the University of Texas Health Science Center at San Antonio found women had a 31% greater risk of developing ...

Bispecific antibodies targeting multiple SARS-CoV-2 sites offer enhanced neutralization against emerging variants, advancing ...

One avenue for new vaccine development is mucosal vaccines. In theory, dosing the vaccine directly into the respiratory tract ...

Germany's foreign intelligence service, the BND, reportedly concluded in 2020 that there was an 80% to 90% probability that ...

When the COVID-19 pandemic first began, we saw how quickly the SARS-CoV-2 virus evolved. New variants emerged with mutations ...

COVID-19 affects hundreds of millions of people worldwide and is often associated with long-term neurological abnormalities.

The lack of available medications in the United States for COVID post-exposure prophylaxis leaves household members in close contact with someone who is infected vulnerable to developing COVID ...

A large-scale French study finds that patients hospitalized with COVID-19 face a significantly higher risk of long-term organ ...